SIM0811
/ Simcere
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 16, 2026
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Subjects
(clinicaltrials.gov)
- P1 | N=56 | Not yet recruiting | Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
New P1 trial
1 to 1
Of
1
Go to page
1